Today: 5 April 2026
Palo Alto Networks stock slips as tariff jitters and AI code-security buzz hit PANW

Palo Alto Networks stock slips as tariff jitters and AI code-security buzz hit PANW

New York, February 23, 2026, 11:46 EST — Regular session

  • Palo Alto Networks dropped roughly 2.5% with other cybersecurity names also sliding in late morning trade.
  • Broader software names slipped as fresh tariff questions and jitters over possible AI shakeups weighed on the sector.
  • Attention shifts now to integration costs, with a March 20 deadline looming for CyberArk notes.

Palo Alto Networks (PANW.O) dropped roughly 2.5% to $144.96 by late morning Monday, with shares dipping as low as $144.24. Volume topped 9 million shares. CrowdStrike sank 8.5%, Zscaler lost 8.7%, and Fortinet was off 4.8%.

Selling followed a broader pullback after President Donald Trump rolled out a new 15% global tariff, jolting markets that were only just recovering from last week’s Supreme Court decision. The S&P 500 software and services index dropped nearly 3%, putting its year-to-date loss at almost 23%, according to Reuters. “The market is just experiencing some profit-taking,” Great Hill Capital chairman Thomas Hayes said. Reuters

Palo Alto shares stayed under pressure Monday, following last week’s guidance cut. The company lowered its adjusted profit target for fiscal 2026, citing increased acquisition expenses. Adjusted EPS is now pegged at $3.65 to $3.70, with revenue in the $11.28 billion to $11.31 billion range. Palo Alto also flagged a $2.3 billion cash outlay in the fiscal third quarter related to its CyberArk deal. Reuters

Palo Alto’s fiscal second-quarter revenue climbed 15% to $2.6 billion, the company said in its Feb. 17 earnings release. Next-Generation Security ARR jumped 33%, landing at $6.3 billion. That ARR figure—annualized recurring revenue—reflects the value of active subscription contracts and serves as a key metric for recurring sales. CEO Nikesh Arora pointed to customers eager “to both modernize and normalize their cybersecurity stack,” with AI accelerating the move to wider platforms. SEC

Some investors are eyeing another pressure point for cybersecurity stocks: the notion that AI-driven tools might chip away at services for which vendors bill clients. Anthropic, an AI startup, has started introducing Claude Code Security—a system that sweeps codebases for weaknesses and proposes fixes. Human review still decides what gets patched. According to Anthropic, the offering is designed to “put this power squarely in the hands of defenders” as they face off against AI-powered threats. The Hacker News

Boards are starting to ask if budgets should move away from monitoring and alerts, leaning more toward automated repairs, according to Merritt Baer, chief security officer at Enkrypt AI. “The real shift is from pattern-matching to hypothesis generation,” Baer said in an interview with VentureBeat. Venturebeat

Analyst opinions are split: some see the selloff as excessive, others as a signal that margin pressure could stick around as Palo Alto works through its acquisitions. Morningstar’s Malik Ahmed Khan attributed the lower profitability “mostly” to those recent deals. Truist Securities analysts, for their part, said they’d “lean in on weakness” if the integration story settles down. Reuters

Still, things could shift for the stock if integration costs climb, synergies show up later than planned, or rivals—especially AI players—step up their code security efforts. In a filing from Feb. 19 related to CyberArk’s 0.00% convertible notes maturing in 2030, Palo Alto disclosed that holders can demand a cash buyback by 5:00 p.m. New York time on March 20, with the actual repurchase scheduled for March 24. SEC

Stock Market Today

  • Telix Pharmaceuticals Names David Gill to Board, Signals Governance Shift Amid Growth Focus
    April 5, 2026, 5:29 PM EDT. Telix Pharmaceuticals (ASX:TLX) appointed David Gill as a Non-Executive Director, set to succeed Dr. Mark Nelson as Chair in May 2026. Gill brings deep radiopharmaceutical and governance expertise, potentially reshaping Telix's strategy balancing growth and oversight. The company's core growth hinges on regulatory and commercial progress of pipeline assets like Pixclara and TLX591-Tx, with heavy R&D and manufacturing investment pressuring near-term earnings. The recent resubmission of TLX101-Px (Pixclara) for FDA approval is a key catalyst. Analysts' forecasts vary widely, with consensus projecting A$1.2 billion revenue and A$111.3 million earnings by 2029, but some cautioning on execution risks. The board change may influence how Telix navigates its development pipeline and investor expectations in the years ahead.
Salesforce stock slides as tariff uncertainty and a Morgan Stanley target cut sharpen focus on earnings
Previous Story

Salesforce stock slides as tariff uncertainty and a Morgan Stanley target cut sharpen focus on earnings

Intel Corporation stock price dips as tariffs rattle tech — what INTC traders watch next
Next Story

Intel Corporation stock price dips as tariffs rattle tech — what INTC traders watch next

Go toTop